PERSPECTIVE article
Front. Public Health
Sec. Public Health Policy
Volume 13 - 2025 | doi: 10.3389/fpubh.2025.1587738
This article is part of the Research TopicTackling Non-Communicable Diseases and Epidemiological Transition in Low- and Middle-Income CountriesView all articles
Measuring Success of Targeted Screening and Prevention for Hemoglobinopathies
Provisionally accepted- 1Sankalp India Foundation, Bangalore, India
- 2Jagriti Innohealth Platforms Pvt Ltd, Bangalore, Karnataka, India
- 3Cure2children Foundation, Firenze, Italy
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
1. Effective screening for hemoglobinopathies prevents affected births. Success relies on counselor quality, testing accuracy, accessibility, timeliness, and demographic factors influencing participation and outcomes. 2. Screening Rate measures the percentage of at-risk women successfully screened and informed, reflecting the program's reach and timeliness. 3. Prevention Index tracks the number of women enrolled per birth prevented, highlighting the program's effectiveness in reducing affected births. 4. These indicators help measure the effectiveness, cost-efficiency, and societal impact of screening programs, guiding improvements and resource allocation.
Keywords: screening, Prevention & control, Hemoglobinopathies, Program Evaluation, Thalassemia and Sickle Cell Disease
Received: 04 Mar 2025; Accepted: 16 Jul 2025.
Copyright: © 2025 Agarwal, Periyavan, Trivedi, Shah, Reddy, Mani, Ankita, Sedai and Faulkner. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Rajat Kumar Agarwal, Sankalp India Foundation, Bangalore, India
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.